While EGFR-TKIs are known substrates for major ABC drug transporters, the circumvention of ABC transporter-mediated drug resistance to EGFR-TKIs by Lingzhi/Yunzhi in experimental cancer models has not been reported. This evidence concerns the gene ABCG2 and cancer.